WNY Asset Management’s AbbVie ABBV Stock Holding History

WNY Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$941K	Buy	+4,328	New	+$960K	0.1%	106
2025 Q3	$1.04M	Buy	4,475 +1,002	+29%	+$204K	0.1%	94
2025 Q2	$645K	Sell	3,473 -533	-13%	-$99.1K	0.07%	117
2025 Q1	$839K	Buy	4,006 +16	+0.4%	+$3.11K	0.1%	101
2024 Q4	$709K	Sell	3,990 -517	-11%	-$95.1K	0.09%	107
2024 Q3	$890K	Sell	4,507 -540	-11%	-$101K	0.1%	98
2024 Q2	$866K	Buy	5,047 +142	+3%	+$23.5K	0.11%	101
2024 Q1	$893K	Buy	4,905 +262	+6%	+$45.2K	0.14%	98
2023 Q4	$719K	Sell	4,643 -17	-0.4%	-$2.48K	0.12%	111
2023 Q3	$695K	Buy	4,660 +98	+2%	+$14.4K	0.14%	99
2023 Q2	$615K	Sell	4,562 -194	-4%	-$28.4K	0.13%	101
2023 Q1	$758K	Sell	4,756 -741	-13%	-$113K	0.18%	88
2022 Q4	$888K	Sell	5,497 -1,007	-15%	-$154K	0.24%	74
2022 Q3	$871K	Sell	6,504 -3,514	-35%	-$504K	0.32%	64
2022 Q2	$1.53M	Buy	10,018 +2,576	+35%	+$394K	0.52%	48
2022 Q1	$1.2M	Sell	7,442 -710	-9%	-$103K	0.37%	61
2021 Q4	$1.11M	Sell	8,152 -285	-3%	-$33.7K	0.33%	61
2021 Q3	$909K	Buy	8,437 +690	+9%	+$78.8K	0.31%	66
2021 Q2	$873K	Buy	7,747 +2,060	+36%	+$232K	0.31%	64
2021 Q1	$615K	Buy	5,687 +2,175	+62%	+$233K	0.25%	68
2020 Q4	$374K	Buy	+3,512	New	+$337K	0.19%	58

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WNY Asset Management's ABBV Position: Q1 2026 in Review

WNY Asset Management opened a new position in AbbVie (ABBV) in Q1 2026: 4,328 shares worth $941K. The stake represents 0.1% of the portfolio and ranks #106 among its holdings. This is a return to the name: WNY Asset Management previously reported a position in ABBV as recently as Q3 2025.

WNY Asset Management first reported a position in ABBV in Q4 2020 and has held it in 21 quarters since. The position peaked at $1.53M in Q2 2022. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

WNY Asset Management held 4,328 shares of AbbVie worth $941K as of Q1 2026.
AbbVie was a new WNY Asset Management position in Q1 2026.
AbbVie made up 0.1% of WNY Asset Management's portfolio in Q1 2026, its #106 holding.
WNY Asset Management first reported a position in AbbVie in Q4 2020 and has held it in 21 quarters since.
WNY Asset Management's AbbVie position peaked at $1.53M in Q2 2022.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on WNY Asset Management's 13F filing for Q1 2026, filed 22 May 2026.